All Times Listed in EST

8:55 am Chair’s Opening Remarks

Regulatory Guidelines

9:00 am Understanding the Multiple Forms an FDA-Regulated Digital Therapeutic Can Take


  • What considerations to make when choosing the regulatory route
  • What digital therapeutics fit under enforcement discretion and what kind of research is needed to support?

9:30 am Digital Legislation in Germany – A Role Model for Others to Follow?

  • Brigitta Monz Global Head Measurement Science, Digital Health Technologies, Roche


  • Getting up to speed with the legislation and what it means for the German market
  • Implications on reimbursement, a current head-scratcher in other markets
  • A good framework – is it one to follow?

10:00 am Virtual Morning Coffee

Becoming Mainstream – Scalability & Commercial Factors to Drive Adoption

10:30 am Panel Discussion – The Buzz Words: Sustainability & Scalability

  • Chris Lento Head of Healthcare Strategic Partnerships , Noom
  • Brigitta Monz Global Head Measurement Science, Digital Health Technologies, Roche
  • Matthias Zenker Senior Vice President & Head, Business Development DTx, GAIA AG
  • Andy Molnar VP, Market Access, Cognoa
  • Georgia Mitsi Executive Director, Sunovian Pharmaceuticals


  • Exploring thought processes behind the different approaches to sustainability and scalability

11:15 am Case Study – How Sidekick Collaborates with Pharma to Drive DTx Innovation


• How Sidekick are scaling and rolling out with big pharma across Europe in five different therapeutic areas
• Initiating partnerships and how to unlock the power of collaboration
• Why and how partnerships with pharma will be a recipe for DTx success

11:45 am Healthier Lives Through Behavior Change


• Noom’s vision & mission to help people everywhere get healthier through behavior change
• Why Noom sees partnerships with life sciences groups as critical to helping more people become healthier
• Lessons learned along the way, and why Noom sees so much potential in the future of digital health

12:15 pm Virtual Networking Lunch

1:15 pm We’re Past the Pioneering Phase, Now it’s Time to Commercialize


• Insight into investors thoughts on DTx and the current commercialization phase
• Why the pace of change is causing investor enthusiasm and driving consumer uptake

1:45 pm Case Study – Lessons Learned from First Year in Digital Therapeutics Development


• Hurdles overcome so far and what sights have been set
• Important considerations when planning for the future
• Steps and analysis to find the right partners to help your journey

2:15 pm Future of DTx Roundtable Discussions:


Following the day’s talks and discussions, the audience will split into groups, selecting one of the below topics for
a knowledge exchange session. Each session will last 45 minutes for audience members to discuss:

The DTx Future Shines Bright


3:00 pm Chair’s Closing Remarks

3:05 pm End of Conference